Ironwood Non Current Assets Total from 2010 to 2024

IRWD Stock  USD 6.74  1.38  17.00%   
Ironwood Pharmaceuticals' Non Current Assets Total are increasing over the years with slightly volatile fluctuation. Non Current Assets Total are expected to dwindle to about 143 M. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2008-12-31
Previous Quarter
270.5 M
Current Value
237.8 M
Quarterly Volatility
131.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ironwood Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ironwood main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 19.9 M or Total Revenue of 231.7 M, as well as many exotic indicators such as Price To Sales Ratio of 3.82, Dividend Yield of 0.0 or Days Sales Outstanding of 142. Ironwood financial statements analysis is a perfect complement when working with Ironwood Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Ironwood Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Ironwood Pharmaceuticals Technical models . Check out the analysis of Ironwood Pharmaceuticals Correlation against competitors.
For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.

Latest Ironwood Pharmaceuticals' Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of Ironwood Pharmaceuticals over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Ironwood Pharmaceuticals' Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ironwood Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
       Timeline  

Ironwood Non Current Assets Total Regression Statistics

Arithmetic Mean149,810,487
Geometric Mean101,829,858
Coefficient Of Variation84.37
Mean Deviation108,539,409
Median95,896,000
Standard Deviation126,389,732
Sample Variance15974.4T
Range365M
R-Value0.57
Mean Square Error11613.9T
R-Squared0.32
Significance0.03
Slope16,109,050
Total Sum of Squares223641.1T

Ironwood Non Current Assets Total History

2024143 M
2023237.8 M
2022319.9 M
2021381.7 M
202063.4 M
201995.9 M
201865.6 M

About Ironwood Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Ironwood Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Ironwood Pharmaceuticals investors use historical funamental indicators, such as Ironwood Pharmaceuticals's Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Ironwood Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Ironwood Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ironwood Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ironwood Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ironwood Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Assets Total237.8 M143 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Ironwood Pharmaceuticals is a strong investment it is important to analyze Ironwood Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ironwood Pharmaceuticals' future performance. For an informed investment choice regarding Ironwood Stock, refer to the following important reports:
Check out the analysis of Ironwood Pharmaceuticals Correlation against competitors.
For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Ironwood Stock analysis

When running Ironwood Pharmaceuticals' price analysis, check to measure Ironwood Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ironwood Pharmaceuticals is operating at the current time. Most of Ironwood Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ironwood Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ironwood Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ironwood Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Ironwood Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ironwood Pharmaceuticals. If investors know Ironwood will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ironwood Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.69)
Earnings Share
(6.45)
Revenue Per Share
2.848
Quarterly Revenue Growth
0.097
Return On Assets
0.1339
The market value of Ironwood Pharmaceuticals is measured differently than its book value, which is the value of Ironwood that is recorded on the company's balance sheet. Investors also form their own opinion of Ironwood Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ironwood Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ironwood Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ironwood Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ironwood Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ironwood Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ironwood Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.